Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medmira
(TSV:
MIR
)
0.0700
UNCHANGED
Streaming Delayed Price
Updated: 3:47 PM EST, Dec 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medmira
< Previous
1
2
Next >
MedMira Reports First Quarter Results FY2026
December 30, 2025
Via
ACCESS Newswire
MedMira Reports FY2025 Fourth Quarter and Year End Financial Results
November 28, 2025
Via
ACCESS Newswire
Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
August 26, 2025
Via
ACCESS Newswire
MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
July 07, 2025
Via
ACCESS Newswire
MedMira Reports Second Quarter Results FY2025
June 30, 2025
Via
ACCESS Newswire
MedMira Reports First Quarter Results FY2025
December 30, 2024
Via
ACCESSWIRE
MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
November 28, 2024
Via
ACCESSWIRE
MedMira Announces the appointment of Vice President of Commercial Operations
October 03, 2024
Via
ACCESSWIRE
MedMira Reports Third Quarter Results FY2024
July 02, 2024
Via
ACCESSWIRE
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
April 17, 2025
Via
ACCESS Newswire
MedMira Reports Second Quarter Results FY2025
April 01, 2025
Via
ACCESS Newswire
MedMira Announces Partnership with MediGroup Physician Services in the United States
February 27, 2025
Via
ACCESS Newswire
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
February 25, 2025
Via
ACCESS Newswire
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
January 21, 2025
Via
ACCESS Newswire
MedMira Announces the Hire of Vice President of Business Development
April 30, 2024
Via
ACCESSWIRE
MedMira Reports Second Quarter Results FY2024
April 01, 2024
Via
ACCESSWIRE
CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products
February 01, 2024
Via
ACCESSWIRE
MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
January 14, 2025
Via
ACCESSWIRE
MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
January 09, 2025
Via
ACCESSWIRE
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
December 24, 2024
Via
ACCESSWIRE
Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada
August 13, 2024
Via
ACCESSWIRE
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
March 13, 2024
Via
ACCESSWIRE
MedMira Reports First Quarter Results FY2024
December 29, 2023
Via
ACCESSWIRE
MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
November 28, 2023
Via
ACCESSWIRE
Corporate Update on Clinical Evaluation of MedMira’s Products
February 01, 2024
Via
ACCESSWIRE
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
December 13, 2023
Via
ACCESSWIRE
Update on MedMira’s Regulatory Path in Canada and the USA
September 27, 2023
Via
ACCESSWIRE
Progress Update on Securities
August 30, 2023
Via
ACCESSWIRE
MedMira Reports Third Quarter Results FY2023
June 29, 2023
Via
ACCESSWIRE
MedMira Reports Second Quarter Results FY2023
April 03, 2023
Via
ACCESSWIRE
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today